Cancel
Tassos Georgiadis
Vice President, Preclinical Development
@
MeiraGTx
1by5vu@ffp1p725.0yf
Sign up to see email
See Linkedin
Known information
- Has been researching virus-mediated gene therapy for over 18 years
- Specializes in AAV gene therapy vector design and neurodegeneration
- Worked at the UCL Institute of Child Health and the UCL Institute of Ophthalmology focusing on ocular disorders and regulation of gene expression
- Sits on the UK Health Research Authority Research Ethics Committee as an Expert Member
- Served as an elected member on the Board of the British Society for Gene and Cell Therapy
- Served as a Scientific Consultant for Athena Vision, a biotechnology company
- Holds a BSc in Genetics from Queen Mary & Westfield College
- Holds a MSc in Human Molecular Genetics from Imperial College University
- Earned a PhD in Molecular Genetics from University College London
About MeiraGTx
MeiraGTx is a biotechnology firm specializing in the development of gene therapies for serious diseases, with a focus on inherited retinal diseases, neurodegenerative diseases, and severe forms of xerostomia.
Report inaccurate information
